LINC02267

Across TCGA pan-cancer cohorts, LINC02267 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC02267’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC02267 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02267 is over-expressed in tumor, although a few such as KICH and ESCA show the opposite, repressed pattern.

LIHC, KICH, and LUSC are the cancer types where LINC02267 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02267 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.140	.001	5	view →
KICH	All	All	−0.016	.005	3	view →
LUSC	All	All	+0.194	.015	2	view →
LUAD	All	All	+0.124	.019	1	view →
HNSC	Male	All	+0.109	.049	1	view →
ESCA	Female	All	−0.033	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC02267–LIHC

Open the LIHC breakdown →